FDA Recalls Infant Teething Tablets
The United States Food and Drug Administration (FDA) has issued a recall of Hyland’s Teething Tablets, according to FDA.gov.
Hyland’s Teething Tablets are intended to provide a temporary relief of infant’s teething symptoms. They are homeopathic and are sold over the counter. The tablets contain a small amount of belladonna, which is a plant with toxic leaves and berries, and contact with it can be very harmful in large doses. The FDA requires the belladonna amounts to be carefully controlled, and in an analysis they found that the tablets do not contain consistent amounts of belladonna. A further inspection at the manufacturing facility showed that the manufacturing operations were not carefully controlled.
The FDA has received reports of medical issues in children taking the tablets, whose symptoms mimic the symptoms of an overdose of belladonna. In addition, because the bottles do not have child restraint caps, some children have eaten more of the tablets than recommended. Some symptoms parents should be on alert for if their child has taken Hyland’s Teething Tablets are seizures, lethargy, muscle weakness, difficulty breathing, constipation or difficulty urinating.
Drug companies have a duty to its customers to manufacture drugs that are safe. Hyland’s Teething Tablets have been shown to contain inconsistent amounts of a plant which can be toxic in large doses, which is a breach of the manufacturer’s duty to its customers. If your child has been made ill by an over-the-counter or prescription drug, contact the St. Louis product liability attorneys at Page Law at 314-322-8515 for a free consultation on your case.
